BASF Shores Up Specialty Amines Supply
BASF is expanding its Verbund site in Ludwigshafen to include production capacity for about 20 specialty amines.
BASF will expand its production capacity at its Verbund site in Ludwigshafen, Germany. The expansion will include the production capacity for about 20 specialty amines by early 2017 with an investment of an undisclosed double-digit million-euro amount, according to the press release.
BASF currently makes approximately 200 different amines including alkyl-, alkanol-, and alkoxyalkylamines, heterocyclic and aromatic, and specialty amines. Last Spring, the company announced the expanded capacity for amines at Verbund and in Nanjing, China, with startup plans expected in 2015.
The investment aims to meet growing demand in Europe, said Stefan Blank, president of BASF Intermediates division, in a press release. In January 2015, BASF announced that it planned to invest up to $65 million USD to expand some of its facilities, including the Ludwigshafen, Germany site, for its Polyvinyl pyrrolidone capabilities.
Source: BASF
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
